Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 3.80
Ask: 4.30
Change: 0.00 (0.00%)
Spread: 0.50 (13.158%)
Open: 4.05
High: 4.29
Low: 4.05
Prev. Close: 4.05
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Avation loss narrows; Franchise Brands profit rises

Thu, 03rd Mar 2022 19:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Avation PLC - Singapore-based commercial passenger aircraft leasing company - For the six months ended December 31, pretax loss narrows to USD15.9 million from USD60.5 million, due to a much lower impairment loss on aircraft and credit losses. Revenue drops 6% year-on-year to USD57.9 million from USD61.3 million. Avation's aircraft fleet stands at 42, however fleet assets declines 7.0% year-on-year to USD1.00 billion as at December 31 from USD1.08 billion at the end of June.

----------

Franchise Brands PLC - Manchester-based owner of ChipsAway, Willow Pumps and Metro Rod brands - For 2021, pretax profit rises 57% year-on-year to GBP5.8 million from GBP3.7 million the year before, on revenue which grows 17% year-on-year to GBP57.7 million from GBP49.3 million, with double digit sales from Metro Rod and Metro Plumb, as well as a strong recovery from the B2C division. Declares final dividend of 0.9 pence per share, bringing total payout to 1.5p, up 36% from 1.1p. Looking ahead, reports strong start to 2022, with continued sales growth in B2B.

----------

Poolbeg Pharma PLC - London-based pharmaceutical company - For the period from incorporation on March 19 to December 31, posts pretax loss of GBP2.3 million and no revenue as the company continues to develop its severe influenza treatment POLB 001.

----------

Crystal Amber Fund Ltd - Guernsey-based investment company - As at December 31, net asset value per share increases 11% year-on-year to 143.19 pence from 128.99p. For the six month period, delivered NAV negative return of 0.8%, compared to a 4.7% positive return from the Numis Small Cap Index.

----------

JPMorgan Global Growth & Income PLC - invests in companies around the world - As at December 31, net asset value per share increases 6.1% year-on-year to 459.1 pence from 432.3p, while for the six month period, NAV total return is 8.2%, compared to a 7.7% return from the MSCI AC World Index.

----------

t42 IoT Tracking Solutions PLC - Jersey-based provider of tracking, security and monitoring solutions for containers and freight - For 2021, operating loss widens to USD2.7 million from USD1.8 million, on revenue which declines 16% year-on-year to USD4.2 million from USD5.0 million due to supply chain issues and a performance turnaround only taking place near the end of 2021.

----------

Allergy Therapeutics PLC - Sussex-based biotechnology firm focused on allergy vaccines - For the six months ended December 31, pretax profit drops 54% to GBP7.3 million from GBP15.8 million a year before, due to a rise in costs and a 10% year-on-year decline in revenue to GBP48.7 million from GBP54.0 million, due to the strategic streamlining of older products. Looking ahead, company has a strong outlook for the full financial year with operating profit on track to meet consensus expectations.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - For the year ended September 30, pretax loss narrows to GBP623,000 from GBP1.4 million the year before, due to smaller impairment charges, and a slight rise in revenue to GBP37,000 from GBP9,000

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
29 Dec 2022 12:14

LONDON MARKET MIDDAY: Covid concerns in China drag stocks lower

(Alliance News) - Stock prices in London at midday continued to be weighed down by the worrying surge in Covid-19 cases as China swiftly re-opens from three years of strict lockdown measures.

Read more
29 Dec 2022 09:26

AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
29 Dec 2022 08:50

LONDON MARKET OPEN: Sea of red as investors fret over Covid in China

(Alliance News) - Stock prices in London opened lower on Thursday amid risk-off sentiment across Europe, as concerns grew about rising Covid cases in China.

Read more
29 Dec 2022 08:22

Allergy Therapeutics shares halve as delayed audit to mean suspension

Alliance News) - Allergy Therapeutics PLC on Thursday said it shares will be suspended next week, due to delays in completing the audit of its annual results.

Read more
8 Dec 2022 11:07

AIM WINNERS & LOSERS: Redcentric boasts "transformational" half-year

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Dec 2022 11:04

Allergy Therapeutics proffers peanut progress despite cost concerns

(Alliance News) - Allergy Therapeutics PLC on Thursday saw shares drop despite the start of its peanut allergy testing trial, after it confirmed that cost control remains a preoccupation for management following a pause in production earlier in the year.

Read more
21 Nov 2022 17:00

Allergy Therapeutics hires interim CFO as Nick Wykeman steps down

(Alliance News) - Allergy Therapeutics PLC on Monday said it appointed Martin Hopcroft as interim chief financial officer, as Nick Wykeman will step down at the end of November.

Read more
28 Oct 2022 11:33

AIM WINNERS & LOSERS: Directa Plus wins deal; Greatland loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
28 Oct 2022 11:10

IN BRIEF: Allergy Therapeutics resumes output; warns on revenue miss

Allergy Therapeutics PLC - West Sussex-based commercial biotechnology company - Says it will resume production at Freeman facility in Worthing, UK on November 14. This follows a short-term voluntary pause as it reviewed its operating processes. Says the pause was planned, to help improve "robustness" of quality systems and build capacity. It was then accelerated when the firm realised capacity could not cope with commercial demand. "The pause in manufacturing occurred during a period of peak production prior to the start of the pollen season in the spring," it says. Consequently, it estimates revenue will be around 13% to 18% lower than market expectations of around GBP80 million, for the year to June 30.

Read more
17 Oct 2022 16:31

TRADING UPDATES: IQE, Trellus Health and Insig sign new agreements

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Oct 2022 14:10

Allergy Therapeutics pauses production at Freeman facility

(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.

Read more
4 Oct 2022 11:19

AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
4 Oct 2022 10:35

Allergy Therapeutics shares down as pauses production at UK facility

(Alliance News) - Allergy Therapeutics PLC shares dropped on Tuesday following production at the Freeman facility, part of its Worthing, UK manufacturing site, being paused.

Read more
4 Oct 2022 10:15

Allergy Therapeutics shares down as pauses production at UK facility

(Alliance News) - Allergy Therapeutics PLC shares dropped on Tuesday following production at the Freeman facility, part of its Worthing, UK manufacturing site, being paused.

Read more
29 Sep 2022 22:08

TRADING UPDATES: H&T plans raise; Joules turnaround continues

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.